![Gregor MacRae](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregor MacRae is a Senior Partner at Appledore Wealth Management LLP.
He was a Non-Executive Director at OKYO Pharma Ltd. from 2019 to 2020 and at Tiziana Life Sciences Ltd. (United Kingdom) in 2020.
He is a graduate of the University of Birmingham.
| Bedrijven | Functie | Begin |
|---|---|---|
Appledore Wealth Management LLP | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Directeur/Bestuurslid | 18-06-2020 |
| WEST AFRICAN MINERALS CORP | Directeur/Bestuurslid | 10-06-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Appledore Wealth Management LLP |
Kies jouw editie
Alle financiële informatie op nationaal niveau
